12 min
Ensysce Biosciences Discusses TAAP and MPAR® Applications and OncoZenge Partnership with The Stock Day Podcast Stock Day Media
-
- Investing
The Stock Day Podcast welcomed Ensysce Biosciences (Nasdaq:ENSC)(“the Company”), a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. CEO of the Company, Dr. Lynn Kirkpatrick, joined Stock Day host Matthew Dunehoo.
The Stock Day Podcast welcomed Ensysce Biosciences (Nasdaq:ENSC)(“the Company”), a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. CEO of the Company, Dr. Lynn Kirkpatrick, joined Stock Day host Matthew Dunehoo.
12 min